Nepal | May 28, 2020

Japan scientists to use “reprogrammed” stem cells to fight Parkinson’s

REUTERS
Share Now:
Japan, Parkinsons disease, stem cell

Jun Takahashi (left), professor at Kyoto University’s Center for iPS Cell Research and Application, attends a news conference in Kyoto, Japan, on July 30, 2018. Photo: Kyodo via Reuters

TOKYO: Japanese scientists said on Monday they will start clinical trials next month on a treatment for Parkinson’s disease, transplanting “reprogrammed” stem cells into brains, seeking a breakthrough in treating the neurodegenerative disorder.

Parkinson’s is caused by a lack of dopamine made by brain cells and researchers have long hoped to use stem cells to restore normal production of the neurotransmitter chemical.

The clinical trials come after researchers at Japan’s Kyoto University successfully used human induced pluripotent stem cells (iPS) to restore functioning brain cells in monkeys last year.

So-called iPS cells are made by removing mature cells from an individual – often from the skin or blood – and reprogramming them to behave like embryonic stem cells. They can then be coaxed into dopamine-producing brain cells.

“This will be the world’s first clinical trial using iPS cells on Parkinson’s disease,” Jun Takahashi, professor at Kyoto University’s Centre for iPS Cell Research and Application, told a news conference.

The centre is headed by Shinya Yamanaka, who in 2012 shared a Nobel Prize for medicine with a British scientist, John Gurdon, for the discovery that adult cells can be transformed back into embryo-like cells.

“We intend to carry on conducting our research carefully, yet expeditiously, in coordination with Kyoto University Hospital, so that new treatment using iPS cells will be brought to patients as soon as possible,” Yamanaka said in a statement.

The fact that the clinical trial uses iPS cells rather than human embryonic cells means the treatment would be acceptable in countries such as Ireland and much of Latin America, where embryonic cells are banned.

Sumitomo Dainippon Pharma Co Ltd has said it aims to manufacture and start selling cellular medicine based on the data from the clinical trials by the year ending March 2023.

The company said, however, the target is solely its own and not a shared goal with Kyoto University.


Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

ANFA president's statement draws controversy

KATHMANDU: All Nepal Football Association (ANFA) President Karma Tsering Sherpa during a video interview said that nationality is weak in the Madhesi community. ANFA President Sherpa, during the interview with Durbin Nepal, made the controversial remark that Madhesi community needed a lesson on n Read More...

Rautahat crosses 100-mark with 35 new COVID-19 cases

RAUTAHAT: The number of COVID-19 positive cases crossed hundred with 35 people testing positive for the infection in Rautahat district, on Wednesday. Among the new cases, eight people have been infected in Gaur Municipality, 16 in Ishanath Municipality, two in Dewahi Gonahi Municipality, two in K Read More...

Worldwide coronavirus cases cross 5.6 million, death toll tops 349,500

More than 5.6 million people have been reported infected with the novel coronavirus globally and 349,555 have died, a Reuters tally shows. Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019. The Americas have em Read More...

'Maintain sexual and reproductive health services during pandemic'

Previous experience from Ebola epidemic in Liberia has already proven that discontinuing heath services unrelated to epidemic response resulted in more deaths than the epidemic itself. Most of the reproductive health services are time sensitive and further delay or denial in seeking services can inc Read More...

FIR against 20 persons for involvement in killing Dalit youth, friends

JAJARKOT: The families of the victims of Chaurjahari incident have filed a First Incident Report (FIR) against 20 persons for their involvement in the killings of Dalit youth Nawaraj BK and his friends, in District Police Office, Jajarkot on Wednesday. As per the FIR, Chaurjahari Municipality-8 c Read More...

Taiwan president pledges humanitarian relief for Hong Kongers

TAIPEI: Taiwanese President Tsai Ing-wen on Wednesday pledged to draw up a plan to give humanitarian relief to people involved in pro-democracy protests in Taiwan's most concrete intervention since a renewal of unrest in Chinese-ruled Hong Kong. China's proposed new security legislation for Read More...

Renault and Nissan rule out merger as they unveil survival plan

PARIS/TOKYO: Renault, Nissan Motor Co and Mitsubishi Motors Corp ruled out a merger on Wednesday and instead said they would cooperate more closely on vehicle development to slash costs and salvage their troubled alliance. The three carmakers are reeling from the coronavirus pandemic which engu Read More...